Stock Research for AGEN

AGEN

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

AGEN Stock Chart & Research Data

The AGEN chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the AGEN chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


AGEN Due diligence Resources & Stock Charts

The AGEN stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View AGEN Detailed Price Forecast - CNN Money CNN View AGEN Detailed Summary - Google Finance
Yahoo View AGEN Detailed Summary - Yahoo! Finance Zacks View AGEN Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View AGEN Trends & Analysis - Trade-Ideas Barrons View AGEN Major Holders - Barrons
NASDAQ View AGEN Call Transcripts - NASDAQ Seeking View AGEN Breaking News & Analysis - Seeking Alpha
Spotlight View AGEN Annual Report - CompanySpotlight.com OTC Report View AGEN OTC Short Report - OTCShortReport.com
TradeKing View AGEN Fundamentals - TradeKing Charts View AGEN SEC Filings - Bar Chart
WSJ View Historical Prices for AGEN - The WSJ Morningstar View Performance/Total Return for AGEN - Morningstar
MarketWatch View the Analyst Estimates for AGEN - MarketWatch CNBC View the Earnings History for AGEN - CNBC
StockMarketWatch View the AGEN Earnings - StockMarketWatch MacroAxis View AGEN Buy or Sell Recommendations - MacroAxis
Bullish View the AGEN Bullish Patterns - American Bulls Short Pains View AGEN Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View AGEN Stock Mentions - StockTwits PennyStocks View AGEN Stock Mentions - PennyStockTweets
Twitter View AGEN Stock Mentions - Twitter Invest Hub View AGEN Investment Forum News - Investor Hub
Yahoo View AGEN Stock Mentions - Yahoo! Message Board Seeking Alpha View AGEN Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for AGEN - SECform4.com Insider Cow View Insider Transactions for AGEN - Insider Cow
CNBC View AGEN Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for AGEN - OTC Markets
Yahoo View Insider Transactions for AGEN - Yahoo! Finance NASDAQ View Institutional Holdings for AGEN - NASDAQ


Stock Charts

FinViz View AGEN Stock Insight & Charts - FinViz.com StockCharts View AGEN Investment Charts - StockCharts.com
BarChart View AGEN Stock Overview & Charts - BarChart Trading View View AGEN User Generated Charts - Trading View




Latest Financial News for AGEN


Botensilimab/Balstilimab Data in MSS CRC Selected for the American Society of Clinical Oncology 2024 Annual Meeting
Posted on Wednesday April 24, 2024

LEXINGTON, Mass., April 24, 2024--Agenus Inc. ("Agenus") (Nasdaq: AGEN), a leader in developing novel immunological agents to treat various cancers, today announced an upcoming presentation from the Phase 1b trial of botensilimab in combination with balstilimab ("BOT/BAL") in patients with relapsed/refractory microsatellite stable colorectal cancer with no active liver metastases (r/r MSS CRC NLM) will be presented at the upcoming American Society of Clinical Oncology (ASCO) Meeting, to be held


Agenus to Provide First Quarter 2024 Financial Report and Corporate Update
Posted on Tuesday April 23, 2024

LEXINGTON, Mass., April 23, 2024--Agenus Inc. ("Agenus") (Nasdaq: AGEN), a leader in developing novel immunological agents to treat various cancers, today announced the Company will release its first quarter 2024 financial results before the market opens on Tuesday, May 7, 2024. Agenus executives will host a conference call and webcast at 8:30 a.m. ET that morning to discuss the results and provide a corporate update.


Agenus (AGEN) Soars 6.8%: Is Further Upside Left in the Stock?
Posted on Monday April 22, 2024

Agenus (AGEN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.


Agenus Announces Updated Phase 1 Data and Progress on BOT/BAL Development in Metastatic MSS Colorectal Cancer
Posted on Friday April 12, 2024

LEXINGTON, Mass., April 12, 2024--Agenus Inc. (NASDAQ: AGEN), a leader in discovering and developing novel immunological agents to treat various cancers, today announced updated results from its Phase 1 clinical trial of BOT/BAL combination therapy in patients with metastatic CRC that is not microsatellite instability-high (MSS) or deficient mismatch repair (dMMR). These findings build upon the compelling clinical activity demonstrated by BOT/BAL across nine different cancer types in Agenus' bro


Stock Market & Investing Books

Enter a stock symbol to view the stock details.